Mason & Associates Inc Amgen Inc Transaction History

Mason & Associates Inc

  • $367 Million
  • Q1 2024

A detailed history of Mason & Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Mason & Associates Inc holds 1,755 shares of AMGN stock, worth $536,766. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,755
Previous 2,035 13.76%
Holding current value
$536,766
Previous $586,000 15.02%
% of portfolio
0.14%
Previous 0.17%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$268.87 - $324.56 $75,283 - $90,876
-280 Reduced 13.76%
1,755 $498,000
Q4 2023

Jan 16, 2024
SELL
$255.7 - $288.46 $80,034 - $90,287
-313 Reduced 13.33%
2,035 $586,000
Q3 2023

Oct 19, 2023
BUY
$218.65 - $271.46 $1,749 - $2,171
8 Added 0.34%
2,348 $631,000
Q2 2023

Jul 20, 2023
BUY
$214.27 - $253.37 $1,928 - $2,280
9 Added 0.39%
2,340 $519,000
Q1 2023

Apr 20, 2023
BUY
$225.79 - $275.2 $69,769 - $85,036
309 Added 15.28%
2,331 $563,000
Q4 2022

Jan 12, 2023
SELL
$229.03 - $291.01 $5,954 - $7,566
-26 Reduced 1.27%
2,022 $0
Q3 2022

Oct 20, 2022
BUY
$224.46 - $253.15 $8,978 - $10,126
40 Added 1.99%
2,048 $462,000
Q2 2022

Jul 26, 2022
BUY
$230.71 - $256.74 $1,614 - $1,797
7 Added 0.35%
2,008 $489,000
Q1 2022

Apr 19, 2022
BUY
$219.27 - $242.57 $187,695 - $207,639
856 Added 74.76%
2,001 $484,000
Q4 2021

Mar 18, 2022
BUY
$198.88 - $227.6 $227,717 - $260,602
1,145 New
1,145 $257,000

Others Institutions Holding AMGN

# of Institutions
2,929
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $164B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mason & Associates Inc Portfolio

Follow Mason & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mason & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email